Peter Fernandes
Company: Bellerophon Therapeutics
Job title: Chief Executive Officer
Seminars:
Adapting Clinical Trial Design & Endpoints for ILD Therapeutic Development: Harnessing Digital Health Technology (DHT) Endpoints 9:00 am
Selecting and expanding the ILD patient population Adapting clinical trials using digital health technology to facilitate remote monitoring of patients health status Incorporating the patient perspective into clinical trial design Assessing digital endpoints across fibrotic ILDs studiesRead more
day: Day Two